Bibliographie (2531)
RCT | The effect of inhaled hypertonic saline on lung structure in children aged 3–6 years with cystic fibrosis.
mardi, 26 juillet 2022 14:54 Écrit par Zouhair SouissiThe effect of inhaled hypertonic saline on lung structure in children aged 3–6 years with cystic fibrosis (SHIP-CT): a multicentre, randomised, double-blind, controlled trial – The Lancet Respiratory Medicine (link to abstract – $ for full-text) Commentary: Inhaled hypertonic saline improves structural airway changes in children with cystic fibrosis – Healio (free registration required)
The post RCT | The effect of inhaled hypertonic saline on lung structure in children aged 3–6 years with cystic fibrosis. appeared first on Links Medicus.
Systematic Review | Antiplatelet agents for the treatment of deep venous thrombosis.
mardi, 26 juillet 2022 14:54 Écrit par Zouhair SouissiAntiplatelet agents for the treatment of deep venous thrombosis – Cochrane Library Summary: Aspirin and similar drugs for the treatment of deep vein thrombosis (DVT) – Cochrane Library
The post Systematic Review | Antiplatelet agents for the treatment of deep venous thrombosis. appeared first on Links Medicus.
Retrospective Cohort Study | Effectiveness of a fourth dose of mRNA COVID-19 vaccine against all-cause mortality in long-term care facility residents and in the oldest old.
lundi, 25 juillet 2022 22:39 Écrit par Zouhair SouissiEffectiveness of a fourth dose of mRNA COVID-19 vaccine against all-cause mortality in long-term care facility residents and in the oldest old: A nationwide, retrospective cohort study in Sweden – The Lancet Regional Health Europe Related: Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in […]
The post Retrospective Cohort Study | Effectiveness of a fourth dose of mRNA COVID-19 vaccine against all-cause mortality in long-term care facility residents and in the oldest old. appeared first on Links Medicus.
![[PREPRINT] RCT | Inhaled fluticasone not beneficial for outpatients with Covid-19.](/media/k2/items/cache/828fdacd49aeb865c4be13426ecef1b3_M.jpg)
[PREPRINT] RCT | Inhaled fluticasone not beneficial for outpatients with Covid-19.
lundi, 25 juillet 2022 22:39 Écrit par Zouhair SouissiInhaled Fluticasone for Outpatient Treatment of Covid-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial – medRxiv News Release: Study finds no benefit to taking fluticasone furoate for COVID-19 symptoms – Duke Clinical Research Institute Commentary: Asthma Drug Fluticasone Fails as Potential COVID-19 Treatment – HealthDay
The post [PREPRINT] RCT | Inhaled fluticasone not beneficial for outpatients with Covid-19. appeared first on Links Medicus.
Guideline Synopsis | Therapy for mild to moderate asthma.
vendredi, 22 juillet 2022 15:05 Écrit par Zouhair SouissiTherapy for Mild to Moderate Asthma – JAMA (free for a limited period) Original Guideline: 2022 GINA Report, Global Strategy for Asthma Management and Prevention Related: Global Initiative for Asthma (GINA) Strategy 2021 – Executive summary and rationale for key changes – European Respiratory Journal
The post Guideline Synopsis | Therapy for mild to moderate asthma. appeared first on Links Medicus.
M-A | Risk factors for asthma exacerbations during pregnancy.
vendredi, 22 juillet 2022 13:42 Écrit par Zouhair SouissiRisk factors for asthma exacerbations during pregnancy: a systematic review and meta-analysis – European Respiratory Review
The post M-A | Risk factors for asthma exacerbations during pregnancy. appeared first on Links Medicus.
RCT | Effect of Nintedanib on progression of systemic sclerosis-associated interstitial lung disease over 100 weeks.
jeudi, 21 juillet 2022 15:56 Écrit par Zouhair SouissiEffect of Nintedanib on Progression of Systemic Sclerosis-Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial – ACR Open Rheumatology Commentary: Durable Efficacy for Drug Preventing Lung Progression in Systemic Sclerosis — One-year results sustained over another 48 weeks – MedPage Today (free registration required)
The post RCT | Effect of Nintedanib on progression of systemic sclerosis-associated interstitial lung disease over 100 weeks. appeared first on Links Medicus.
RCT | Using a smartphone application maintains physical activity following pulmonary rehabilitation in patients with COPD.
jeudi, 21 juillet 2022 15:56 Écrit par Zouhair SouissiUsing a smartphone application maintains physical activity following pulmonary rehabilitation in patients with COPD: a randomised controlled trial – Thorax
The post RCT | Using a smartphone application maintains physical activity following pulmonary rehabilitation in patients with COPD. appeared first on Links Medicus.
Retrospective cohort study | Impact of ethnicity on the accuracy of measurements of oxygen saturations.
jeudi, 21 juillet 2022 15:56 Écrit par Zouhair SouissiImpact of ethnicity on the accuracy of measurements of oxygen saturations: A retrospective observational cohort study – eClinicalMedicine Related: Racial and Ethnic Discrepancy in Pulse Oximetry and Delayed Identification of Treatment Eligibility Among Patients With COVID-19 – JAMA Internal Medicine Racial Bias in Pulse Oximetry Measurement – New England Journal of Medicine Pulse Oximetry for […]
The post Retrospective cohort study | Impact of ethnicity on the accuracy of measurements of oxygen saturations. appeared first on Links Medicus.
Review | New antibiotics for hospital-acquired pneumonia and ventilator-associated pneumonia.
mercredi, 20 juillet 2022 16:26 Écrit par Zouhair SouissiNew Antibiotics for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia – Seminars in Respiratory and Critical Care Medicine
The post Review | New antibiotics for hospital-acquired pneumonia and ventilator-associated pneumonia. appeared first on Links Medicus.
